Sepsis is defined as life-threatening organ dysfunction caused by a deregulated immune
host response to infection. The emergence of the severe acute respiratory syndrome …

Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …

Severe acute respiratory syndrome coronavirus-2 and the related coronavirus disease-19
(COVID-19) is a worldwide emerging situation, which was initially reported in December …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …

Mesenchymal stromal cells (MSC) have immune regulatory and tissue regenerative
properties. MSCs are being studied as a therapy option for many inflammatory and immune …

More than seven months into the coronavirus disease-19 (COVID-19) pandemic, infection
from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over …

The devastating global impact of the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus …

Background Treatment of acute respiratory distress syndrome (ARDS) associated with
COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and supportive …

Mesenchymal stromal cells (MSCs) constitute a heterogeneous population of stromal cells
with immunomodulatory and regenerative properties that support their therapeutic use …

Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …